A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Clinical trial NCT06389292 · RECRUITING
Trial details
- NCT number
- NCT06389292
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2028-05-25
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.